| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |